Cabinet Secretary Ministry of health Aden Duale on Thursday launched the long-acting injectable HIV pre-exposure prophylaxis (PrEP), Lenacapavir.
The launch marked the first phase of the national rollout and reinforcing Kenya’s commitment to ending the HIV epidemic through innovative, people-centred prevention solutions.
“Aden Duale has launched the long-acting injectable HIV pre-exposure prophylaxis (PrEP), Lenacapavir, marking the first phase of the national rollout and reinforcing Kenya’s commitment to ending the HIV epidemic through innovative, people-centred prevention solutions, “Read a statement.
The event was attended by Principal Secretary for Medical Services Dr. Ouma Oluga; NASCOP CEO Dr. Andrew Mulwa; Director of Family Health Dr. Issak Bashir.
Others included Dagoretti North MP Hon. Beatrice Elachi; and representatives from key partners including Dr. Jacqueline Kitulu (Global Fund), Dr. Richard Amenyah (UNAIDS), Dr. Neema Kimambo (WHO), Jennifer Galbraith (USG) and Mary Nyaguthi (AHF).